
Daniel M. Libby
Dec 25, 2024, 09:42
The association of oncogene driver mutations with recurrence and survival in stage I NSCLC
Clinical Lung Cancer shared an article by Daniel M. Libby on X:
“Explore a new article evaluating the association of oncogene driver mutations with recurrence and survival in stage I non-small cell lung cancer (NSCLC).”
Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Non-small Cell Lung Cancer.
Authors: Daniel M. Libby, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35
Aug 23, 2025, 22:10
Aug 23, 2025, 21:42
Aug 23, 2025, 21:31
Aug 23, 2025, 20:55
Aug 23, 2025, 20:22